Events and webinars

Carve outs, Divestments and Spin-Offs – How to Sell Businesses and Assets​

In 2021 we saw an increasing number of carve out transactions as businesses spun off non-core or non-performing businesses or sold businesses to obtain capital for other activities. These...

Tokyo: Life Sciences and Health Care Horizons 2019

Key Life Sciences issues for Japanese companies: focus on (1) digital health, (2) cell, tissue, and gene therapies, and (3) cross-border transactions.

Exciting Trends in Japanese Tech M&A

In 2018 business headlines were dominated by Japanese M&A deals at levels unprecedented since the 1980s. This trend is expected to continue in tech M&A with Japanese investors...

Loading data